Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$36.98
-1.2%
$31.65
$23.69
$37.58
$16.19B0.68892,600 shs604,204 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
+1.49%+1.73%+23.70%+31.96%+22.48%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
3.1805 of 5 stars
1.04.02.50.03.40.03.8
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.00
Hold$36.00-3.07% Downside

Current Analyst Ratings Breakdown

Latest LWI, SNN, BHMU, and TFG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/18/2025
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$28.00 ➝ $36.00
(Data available from 8/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$5.81B2.80$3.18 per share11.68$12.64 per share2.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$412M$2.1617.2018.571.02N/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.892.40%N/A41.20%N/A

Latest LWI, SNN, BHMU, and TFG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2025
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
semi-annual$0.28502.1%10/3/202510/3/202511/7/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.60
3.00
1.40

Institutional Ownership

CompanyInstitutional Ownership
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%

Insider Ownership

CompanyInsider Ownership
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
17,349437.98 million433.60 millionOptionable

Recent News About These Companies

Smith & Nephew: US bank upbeat after meetings with management
Smith & Nephew: Doing Better And Still Offers Value

New MarketBeat Followers Over Time

Media Sentiment Over Time

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$36.98 -0.44 (-1.16%)
Closing price 03:59 PM Eastern
Extended Trading
$36.99 +0.02 (+0.04%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.